Our results indicate that near-complete loss of ARPC1B expression results in platelet abnormalities including microthrombocytes and spreading defects, and also eczema, leukocytoclastic vasculitis, eosinophilia and elevated IgA and IgE. This evidence concerns the gene IGHE and hypersensitivity vasculitis.